Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
34,66 USD | +3,87% | +0,90% | +36,14% |
Métier
Nombre d'employés: 187
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Small Molecule Therapeutics
100,0
%
| 47 | 100,0 % | 79 | 100,0 % | +67,84% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 47 | 100,0 % | 79 | 100,0 % | +67,84% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Nello Mainolfi
FOU | Founder | 45 | 01/09/15 |
Bruce Jacobs
DFI | Director of Finance/CFO | 54 | 15/07/19 |
Juliet Williams
CTO | Chief Tech/Sci/R&D Officer | - | 05/05/21 |
Kevin Dushney
CTO | Chief Tech/Sci/R&D Officer | - | 03/02/21 |
Jared Gollob
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/09/18 |
Vijay Sabesan
CTO | Chief Tech/Sci/R&D Officer | 51 | 06/12/21 |
Jeremy Chadwick
COO | Chief Operating Officer | 61 | 22/05/23 |
Investor Relations Contact | - | 01/07/23 | |
Aimee Mishkin
LAW | General Counsel | - | 01/04/20 |
Melissa Brody
PRN | Corporate Officer/Principal | - | 02/11/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 28/03 |
Joanna Horobin
BRD | Director/Board Member | 69 | 01/05/18 |
John Maraganore
BRD | Director/Board Member | 60 | 17/01/22 |
Elena Ridloff
BRD | Director/Board Member | 44 | 12/03/21 |
Pamela Esposito
BRD | Director/Board Member | 50 | 04/09/20 |
Jeffrey Albers
BRD | Director/Board Member | 52 | 01/07/20 |
Leigh Morgan
BRD | Director/Board Member | - | 08/07/22 |
Victor Sandor
BRD | Director/Board Member | 57 | 03/11/22 |
Nello Mainolfi
FOU | Founder | 45 | 01/09/15 |
Director/Board Member | 35 | 01/03/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 61 111 678 | 60 515 185 ( 99,02 %) | 0 | 99,02 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+36,14% | 2,05 Md | |
+1,77% | 42,75 Md | |
+47,70% | 41,61 Md | |
+12,24% | 41,34 Md | |
-8,83% | 26,59 Md | |
+7,44% | 25,49 Md | |
-23,01% | 18,12 Md | |
+30,56% | 12,24 Md | |
-1,82% | 11,76 Md | |
+8,35% | 11 Md |
- Bourse
- Actions
- Action KYMR
- Société Kymera Therapeutics, Inc.